News >

Novel Agents Generate Excitement in Advanced HCC, Cholangiocarcinoma

Caroline Seymour
Published: Tuesday, Jan 14, 2020

Atif Hussein, MD, Hematologist/Oncologist, and Chief of Oncology/Hematology Services, Memorial Cancer Institute, Memorial Healthcare System

Atif Hussein, MD

Treatment for patients with advanced hepatocellular carcinoma (HCC) continues to evolve with several promising combinations, according to Atif Hussein, MD, a hematologist/oncologist at Memorial Healthcare System.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication